Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • VitalHub (VHI) has acquired UK-based S12 Solutions
  • S12 Solutions is a digital platform helping professionals complete the UK’s Mental Health Act 1983 processes
  • S12 Solutions has a recurring revenue base of C$2,617,000
  • This is VitalHub’s 10th acquisition since 2017
  • VitalHub is down 3.00 per cent on the day, with shares trading at $2.91 at 3:33 pm ET

VitalHub (VHI) has acquired UK-based S12 Solutions.

S12 Solutions helps mental health professionals complete the UK’s Mental Health Act 1983 processes.

S12 Solutions is a digital platform, which connects Approved Mental Health Professionals (AMHP) with approved section 12 doctors for MHA assessments in England. Health professionals are able to find available, local doctors, create s.12 doctor claims, and both AMHPs and doctors can create, complete and share electronic statutory MHA forms.

S12 Solutions has a recurring revenue base of C$2,617,000 which represents almost all of its revenue and adds to VitalHub’s growing Annualized Contract Value (ACV).

VitalHub’s ACV, including the company’s recently-announced acquisition of selected assets of Jayex Healthcare and the acquisition of S12 Solutions, now stands at $18,187,000.

This is VitalHub’s 10th acquisition since 2017 and marks the company’s continued expansion into the growing mental health patient-care sector.

“S12 is a powerful platform with enormous potential, addressing the remarkable need for health and social care systems to work together and gain access to registered professionals for urgent and time sensitive assessments of patients.

The need to locate professionals during crisis situations continues to be an important factor in ensuring patients in need are supported by professionals best suited to their needs. S12 Solutions has developed a platform that enables best-in-class response, built with tremendous vision and understanding, resulting in a better solution than what currently exists.

With VitalHub’s significant infrastructure and global footprint, we see a tremendous opportunity to leverage this technology, both in its application surrounding mental health and toward disrupting other market verticals where we believe this technology can be impactful,” said VitalHub Corp. CEO Dan Matlow.

VitalHub is down 3.00 per cent on the day, with shares trading at $2.91 at 3:33 pm ET.

More From The Market Herald

" BioHarvest Sciences (CSE:BHSC) appoints Steven Lehrer to its advisory board

BioHarvest Sciences (BHSC) has appointed Steven Lehrer as its newest advisory board member, effective immediately.

" CloudMD (TSXV:DOC) Receives U.S. patent approval

CloudMD Software & Services Inc. (DOC) has received US patent approval for its Real Time Intervention Platform.

" NervGen Pharma (TSXV:NGEN) introduces Spinal Cord Injury Board

NervGen Pharma Corp. (NGEN) has introduced its Spinal Cord Injury (SCI) Clinical Advisory Board.
Medicenna Therapeutics Corp - CEO, Fahar Merchant

" Medicenna (TSX:MDNA) receives FDA clearance to expand MDNA11 study

Medicenna Therapeutics (MDNA) has received FDA approval to expand the Phase 1/2 ABILITY study of MDNA11 to clinical trial sites in the US.